TCG Crossover GP I, LLC 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:25 pm Purchase | 2025-09-30 | 13G | Cogent Biosciences, Inc. COGT | TCG Crossover GP I, LLC | 6,798,162 4.800% | 1,167,120 (+20.73%) | Filing |
| 2024-02-09 4:22 pm Purchase | 2023-12-31 | 13G | Cogent Biosciences, Inc. COGT | TCG Crossover GP I, LLC | 5,631,042 6.500% | 2,000,000 (+55.08%) | Filing |
| 2023-02-14 2:23 pm Purchase | 2022-12-31 | 13G | Cogent Biosciences, Inc. COGT | TCG Crossover GP I, LLC | 3,631,042 5.200% | 3,631,042 (New Position) | Filing |